Ticker: AURX

Nuo Therapeutics, Inc. (OTCMKTS: AURX) has released its financial results for the second quarter of 2025, revealing both opportunities and challenges ahead. Positive Aspects: Total Revenue: Revenue increased to $700,202 for Q2 2025, up from $364,773 in Q2 2024, showing a growth attributed mainly...